rs7956880
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_016816.4(OAS1):c.180+143A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.812 in 696,950 control chromosomes in the GnomAD database, including 231,987 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.85 ( 55185 hom., cov: 31)
Exomes 𝑓: 0.80 ( 176802 hom. )
Consequence
OAS1
NM_016816.4 intron
NM_016816.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00100
Publications
6 publications found
Genes affected
OAS1 (HGNC:8086): (2'-5'-oligoadenylate synthetase 1) This interferon-induced gene encodes a protein that synthesizes 2',5'-oligoadenylates (2-5As). This protein plays a key role in innate cellular antiviral response, and has been implicated in other cellular processes like cell growth and apoptosis. Alternative splicing results in multiple transcript variants with different enzymatic activities. Polymorphisms in this gene have been associated with susceptibility to viral infection, including SARS-CoV-2, and diabetes mellitus, type 1. This gene is located in a cluster of related genes on chromosome 12. [provided by RefSeq, May 2022]
OAS1 Gene-Disease associations (from GenCC):
- pulmonary alveolar proteinosis with hypogammaglobulinemiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 12-112907362-A-C is Benign according to our data. Variant chr12-112907362-A-C is described in ClinVar as Benign. ClinVar VariationId is 1269600.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.97 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OAS1 | NM_016816.4 | c.180+143A>C | intron_variant | Intron 1 of 5 | ENST00000202917.10 | NP_058132.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| OAS1 | ENST00000202917.10 | c.180+143A>C | intron_variant | Intron 1 of 5 | 1 | NM_016816.4 | ENSP00000202917.5 |
Frequencies
GnomAD3 genomes AF: 0.847 AC: 128777AN: 152052Hom.: 55136 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
128777
AN:
152052
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.802 AC: 436970AN: 544780Hom.: 176802 AF XY: 0.799 AC XY: 226119AN XY: 283136 show subpopulations
GnomAD4 exome
AF:
AC:
436970
AN:
544780
Hom.:
AF XY:
AC XY:
226119
AN XY:
283136
show subpopulations
African (AFR)
AF:
AC:
13872
AN:
14376
American (AMR)
AF:
AC:
16402
AN:
19598
Ashkenazi Jewish (ASJ)
AF:
AC:
9800
AN:
14172
East Asian (EAS)
AF:
AC:
31622
AN:
32052
South Asian (SAS)
AF:
AC:
34879
AN:
45878
European-Finnish (FIN)
AF:
AC:
34758
AN:
43842
Middle Eastern (MID)
AF:
AC:
1515
AN:
2132
European-Non Finnish (NFE)
AF:
AC:
270669
AN:
343808
Other (OTH)
AF:
AC:
23453
AN:
28922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
4060
8120
12179
16239
20299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2782
5564
8346
11128
13910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.847 AC: 128890AN: 152170Hom.: 55185 Cov.: 31 AF XY: 0.846 AC XY: 62929AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
128890
AN:
152170
Hom.:
Cov.:
31
AF XY:
AC XY:
62929
AN XY:
74390
show subpopulations
African (AFR)
AF:
AC:
40040
AN:
41522
American (AMR)
AF:
AC:
13026
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2340
AN:
3468
East Asian (EAS)
AF:
AC:
5149
AN:
5186
South Asian (SAS)
AF:
AC:
3732
AN:
4812
European-Finnish (FIN)
AF:
AC:
8426
AN:
10592
Middle Eastern (MID)
AF:
AC:
213
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53496
AN:
67982
Other (OTH)
AF:
AC:
1770
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
980
1960
2940
3920
4900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3064
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.